开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2024-08-27 1206696em63(暂无昵称) 来自北京

投稿命中率:5.0
偏重的研究方向：临床研究;肾病
经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好

21 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2019-03-18 1e11c33em06(暂无匿称)

审稿速度:2.0 | 投稿命中率:25.0
经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。

476 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2021-12-28 rayms

讨论一般分几段？

303 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

文章的局限性是什么？

263 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

有没有经验分享

429 0

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2016-08-22 ms1560573802851675

最近怎么都没有评论的，刚投了一篇，祝我好用

435 0

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2014-06-02 liuyanqiong

审稿速度:6.0 | 投稿命中率:5.0
经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！

789 0

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2013-08-17 小罗

审稿速度:2.0 | 投稿命中率:25.0
经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。

843 0

[GetPortalCommentsPageByObjectIdResponse(id=2222636, encodeId=c8df222263619, content=投稿命中率:5.0 偏重的研究方向：临床研究;肾病 经验分享：肾内科经典top期刊，偏重临床，投过去5天秒拒，拒稿速度挺快的，也挺好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Tue Aug 27 10:37:21 CST 2024, time=2024-08-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=568273, encodeId=f3445682e361, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：肾内科top杂志之一，偏临床。近期刚中一篇，接受率10-15%左右，比较难，要求数据质量高或者有一定创新性解决临床问题。一般经历一次大修，一到三次小修，整个过程半年左右，有专业的统计编辑审查，非常严格，后期估计还要等两三个月才能online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210219/98390246eba04cae8ae80b518ce579fe/1edf98cf825b41f4aa6b6c3cf8fd416e.jpg, createdBy=2bb61953230, createdName=1e11c33em06(暂无匿称), createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086455, encodeId=0d501086455af, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086456, encodeId=ad791086456ea, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578597, encodeId=60c35e859759, content=有没有经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833329, encodeId=3557833329ff, content=最近怎么都没有评论的，刚投了一篇，祝我好用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Mon Aug 22 23:20:06 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503291, encodeId=285a50329116, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：审稿非常严格，有专业的杂志编辑审稿，还有杂志内部的统计学家提出各种统计修改意见。要求很多！经过大修，一次小修，二次小修，最终接受大约4个半月，出版估计也不会太快，还有很多文章等待排期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=789, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=854169690, createdName=liuyanqiong, createdTime=Mon Jun 02 23:09:00 CST 2014, time=2014-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498484, encodeId=a4a349848412, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们投搞的是卒中患者慢性肾脏病的一篇文章，审稿2个月，大修一次，小修一次，提的意见很中肯，收获很多，最后接收，共用了3个半月时间。感觉编辑很认真，收获大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=843, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=小罗, createdTime=Sat Aug 17 22:15:00 CST 2013, time=2013-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489174, encodeId=8f194891e4a8, content=苛刻，比较难，我在透析的两篇都被拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=906, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 18:32:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]

2012-06-28 匿名用户

苛刻，比较难，我在透析的两篇都被拒了。

906 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务